- Federal agenciesCreates federal standards protecting donor consent and disposition across state lines.
- Potential benefitImproves traceability and chain-of-custody, potentially reducing illicit sales and misuses.
- Potential benefitLikely increases public trust in donations to education and research institutions.
Consensual Donation and Research Integrity Act of 2025
Referred to the House Committee on Energy and Commerce.
The bill amends the Public Health Service Act to require entities that acquire and sell for profit whole human bodies or body parts (for non-transplant purposes) to register with the HHS Secretary. It mandates inspections, recordkeeping, chain-of-custody labeling and packaging, limits on use and disclosure of donor-identifiable information, and requirements for disposition.
Progressives emphasize donor protections and privacy benefits
Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transplant educational and research uses.
The bill amends the Public Health Service Act to require entities that acquire and sell for profit whole human bodies or body parts (for non-transplant purposes) to register with the HHS Secretary.
It mandates inspections, recordkeeping, chain-of-custody labeling and packaging, limits on use and disclosure of donor-identifiable information, and requirements for disposition.
The Secretary may assess fees, suspend or revoke registrations, and violations carry fines under Title 18 and a prohibition on label falsification.
Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and procedural hurdles reduce odds.
Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transplant educational and research uses. It defines key obligations, definitions, and sanctions while delegating implementation specifics to the Secretary.
Progressives emphasize donor protections and privacy benefits
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenImposes new compliance costs and administrative burdens on for‑profit body and tissue brokers.
- Potential burdenCould reduce available specimen supply if sellers exit due to regulatory costs or uncertainty.
- Potential burdenLabeling requirements including donor identifiers raise potential privacy and confidentiality concerns.
Why the argument around this bill splits.
Progressives emphasize donor protections and privacy benefits
Likely supportive because the bill strengthens consent, privacy, and respectful treatment of donated remains used in research and education.
It addresses documented abuses by commercial body brokers by requiring transparency, records, and disposal obligations.
Supporters may nonetheless seek stronger enforcement funding and civil remedies for harmed families.
Generally favorable as a targeted consumer-protection and transparency measure balancing research needs.
The bill appears administrable but raises pragmatic questions about fee levels, regulatory overlap with states, and enforcement capacity.
Centrists will weigh benefits against administrative cost and clarity about interactions with existing laws.
Mixed to skeptical: supports protecting donors from abuse but worries the bill expands federal regulation into areas traditionally governed by states and funeral professionals.
Concerns include regulatory burden, fees, inspections, and potential interference with medical research supply chains.
Conservatives may push for narrower federal scope or stronger state primacy.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and procedural hurdles reduce odds.
- Cost and adequacy of fee revenue and appropriations
- How "sell for profit" will be interpreted and litigated
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize donor protections and privacy benefits
Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and pro…
Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transp…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.